Pathology's new role: defining disease process and protective responses.
作者信息
Perry George, Castellani Rudy J, Moreira Paula I, Lee Hyoung-Gon, Zhu Xiongwei, Smith Mark A
机构信息
College of Sciences, University of Texas, San Antonio, Texas, USA.
出版信息
Int J Clin Exp Pathol. 2008 Jan 1;1(1):1-4.
Abstract
摘要
相似文献
1
Pathology's new role: defining disease process and protective responses.
Int J Clin Exp Pathol. 2008 Jan 1;1(1):1-4.
2
Pathology's Stepchild.
Arch Pathol Lab Med. 2017 Feb;141(2):186-189. doi: 10.5858/arpa.2016-0176-ED. Epub 2016 Dec 28.
3
Pathology's responsiblity in educational reform.
Am J Pathol. 1968 Jul;53(1):183-7.
4
Pathology's "Mighty Mo".
Am J Clin Pathol. 1962 Jan;37:3-9. doi: 10.1093/ajcp/37.1.3.
5
[Minutes of the meeting of the German Society of Pathology's Working Group on pneumopathology (Freiburg, 7.6.2009)].
Pathologe. 2009 Dec;30 Suppl 2:239-40. doi: 10.1007/s00292-009-1179-3.
6
Pathology's Place among the Medical Sciences.
Br Med J. 1938 Dec 3;2(4065):1162-3.
7
Pathology's Expanding Boundaries.
Br Med J. 1959 Sep 5;2(5148):354.
8
Integrity--a look at pathology's record.
Pathologist. 1978 Jul;32(7):412-4.
9
[Minutes of the meeting of the German Society of Pathology's Working Group on Information Technology: Freiburg, 04.06.2009].
Pathologe. 2009 Dec;30 Suppl 2:230-1. doi: 10.1007/s00292-009-1177-5.
10
The evolving revolution of pathology's role in renal medical diseases.
Arch Pathol Lab Med. 2009 Feb;133(2):178-80. doi: 10.5858/133.2.178.
引用本文的文献
1
Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease.
Acta Neuropathol Commun. 2014 Sep 18;2:135. doi: 10.1186/s40478-014-0135-5.
本文引用的文献
1
Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?
Expert Rev Neurother. 2007 May;7(5):473-85. doi: 10.1586/14737175.7.5.473.
2
FAD mutants unable to increase neurotoxic Abeta 42 suggest that mutation effects on neurodegeneration may be independent of effects on Abeta.
J Neurochem. 2007 May;101(3):674-81. doi: 10.1111/j.1471-4159.2006.04391.x. Epub 2007 Jan 24.
3
Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease.
J Neurosci. 2007 Jan 24;27(4):796-807. doi: 10.1523/JNEUROSCI.3501-06.2007.
4
Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses.
J Pharmacol Exp Ther. 2007 Jun;321(3):823-9. doi: 10.1124/jpet.106.114009. Epub 2007 Jan 17.
5
Neuropathology of Alzheimer disease: pathognomonic but not pathogenic.
Acta Neuropathol. 2006 Jun;111(6):503-9. doi: 10.1007/s00401-006-0071-y. Epub 2006 Apr 27.
6
Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.
J Neurochem. 2006 Feb;96(3):732-42. doi: 10.1111/j.1471-4159.2005.03578.x. Epub 2006 Jan 9.
7
Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain.
Free Radic Biol Med. 2002 Nov 1;33(9):1194-9. doi: 10.1016/s0891-5849(02)01021-3.
8
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
Science. 2002 Jul 19;297(5580):353-6. doi: 10.1126/science.1072994.
9
Predicting the failure of amyloid-beta vaccine.
Lancet. 2002 May 25;359(9320):1864-5. doi: 10.1016/S0140-6736(02)08695-6.
10
Alzheimer's disease. Unravelling the disease process.
Lancet. 2001 Dec;358 Suppl:S1. doi: 10.1016/s0140-6736(01)07014-3.
Zotero 插件